Recommendations for screening and early detection of common cancers in India - 30/06/15

Doi : 10.1016/S1470-2045(15)00078-9

Preetha Rajaraman, DrPhD ^a,^⁎ , Benjamin O Anderson, ProfMD ^b, Partha Basu, MD ^c, Jerome L Belinson, ProfMD ^d, Anil D’ Cruz, ProfMS ^e, Preet K Dhillon, PhD ^f, Prakash Gupta, DSc ^g, Tenkasi S Jawahar, MA ^h, Niranjan Joshi, PhD ⁱ, Uma Kailash, PhD ^j, Sharon Kapambwe, MBChB ^k, Vishwa Mohan Katoch, MD ^h, Suneeta Krishnan, PhD ^l, Dharitri Panda, MPhil ^j, R Sankaranarayanan, MD ^m, Jerard M Selvam, MD ⁿ, Keerti V Shah, ProfPhD ^o, Surendra Shastri, ProfMD ^p, Krithiga Shridhar, MDS ^f, Maqsood Siddiqi, ProfPhD ^q, Sudha Sivaram, DrPH ^a, Tulika Seth, MD ^r, Anurag Srivastava, ProfMS ^r, Edward Trimble, MD ^a, Ravi Mehrotra, MD ^j
^a Center for Global Health, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA
^b Departments of Surgery and Global Health Medicine, University of Washington, Seattle, WA, USA
^c Department of Gynecological Oncology, Chittaranjan National Cancer Institute, Kolkata, India
^d Preventive Oncology International and Department of Surgery, Women’s Health Institute, Lerner School of Medicine, Cleveland Clinic, Cleveland, OH, USA
^e Department of Head and Neck Services, Tata Memorial Hospital, Mumbai, India
^f Centre for Control of Chronic Conditions, Public Health Foundation of India, Gurgaon, India
^g Healis-Sekhsaria Institute for Public Health, Navi Mumbai, India
^h Indian Council of Medical Research, New Delhi, India
ⁱ Healthcare Technology Innovation Centre, IIT Madras Research Park, Chennai, India
^j Institute of Cytology and Preventive Oncology, Noida, India
^k Africa Centre of Excellence for Women’s Cancer Control, Centre for Infectious Disease Research, Lusaka, Zambia
^l Women’s Global Health Imperative, Research Triangle Institute International, San Francisco, CA, USA
^m Early Detection & Prevention Section and Screening Group, International Agency for Research on Cancer, Lyon, France
ⁿ Tamil Nadu Health Systems Project, Chennai, India
^o Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
^p Department of Preventive Oncology, Tata Memorial Center, Mumbai, India
^q Cancer Foundation of India, Kolkata, India
^r All India Institute of Medical Sciences, New Delhi, India

^*Correspondence to: Dr P Rajaraman, Center for Global Health, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD 20892-9760, USA

Summary

Cancers of the breast, uterine cervix, and lip or oral cavity are three of the most common malignancies in India. Together, they account for about 34% of more than 1 million individuals diagnosed with cancer in India each year. At each of these cancer sites, tumours are detectable at early stages when they are most likely to be cured with standard treatment protocols. Recognising the key role that effective early detection and screening programmes could have in reducing the cancer burden, the Indian Institute for Cytology and Preventive Oncology, in collaboration with the US National Cancer Institute Center for Global Health, held a workshop to summarise feasible options and relevant evidence for screening and early detection of common cancers in India. The evidence-based recommendations provided in this Review are intended to act as a guide for policy makers, clinicians, and public health practitioners who are developing and implementing strategies in cancer control for the three most common cancers in India.

Le texte complet de cet article est disponible en PDF.